Literature DB >> 15465603

Early administration of IL-12 suppresses EAE through induction of interferon-gamma.

Bruno Gran1, Niansheng Chu, Guang-Xian Zhang, Shuo Yu, Yonghai Li, Xiao-Han Chen, Malek Kamoun, Abdolmohamad Rostami.   

Abstract

Recent findings have shown that IL-12, a key inducer of Th1 cell development, is not required in the pathogenesis of experimental autoimmune encephalomyelitis (EAE) as severe CNS inflammatory demyelination can develop in the absence of IL-12 or IL-12 responsiveness. These data raised the possibility of an immunomodulatory action of IL-12 in this disease model. We show here that IL-12 suppresses MOG35-55-induced EAE in the C57BL/6 mouse when administered during the early induction phase of the disease. The inhibitory effect is interferon-gamma-(IFN-gamma)-dependent, as clearly shown by lack of suppression in IFN-gamma-deficient mice, and is also accompanied by inhibition of mRNA expression of the proinflammatory cytokine IL-17.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465603     DOI: 10.1016/j.jneuroim.2004.07.019

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

Review 1.  Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.

Authors:  Stephen C Juvet; Li Zhang
Journal:  J Mol Cell Biol       Date:  2012-02       Impact factor: 6.216

Review 2.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 3.  Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease.

Authors:  Ali Raza; Wajeeha Yousaf; Ralph Giannella; Mohamed Tarek Shata
Journal:  Expert Rev Clin Immunol       Date:  2012-02       Impact factor: 4.473

4.  mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.

Authors:  Heth R Turnquist; Jon Cardinal; Camila Macedo; Brian R Rosborough; Tina L Sumpter; David A Geller; Diana Metes; Angus W Thomson
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

5.  Accelerated thymocyte maturation in IL-12Rβ2-deficient mice contributes to increased susceptibility to autoimmune inflammatory demyelination.

Authors:  B Gran; S Yu; G X Zhang; A Rostami
Journal:  Exp Mol Pathol       Date:  2010-06-30       Impact factor: 3.362

Review 6.  In search of magic bullets: the golden age of immunotherapeutics.

Authors:  John J O'Shea; Yuka Kanno; Andrew C Chan
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

Review 7.  Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).

Authors:  Cris S Constantinescu; Nasr Farooqi; Kate O'Brien; Bruno Gran
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

8.  Th17 cells induce Th1-polarizing monocyte-derived dendritic cells.

Authors:  Matthew G Davidson; Michael N Alonso; Robert Yuan; Robert C Axtell; Justin A Kenkel; Megan M Suhoski; Joseph C González; Lawrence Steinman; Edgar G Engleman
Journal:  J Immunol       Date:  2013-06-21       Impact factor: 5.422

9.  IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.

Authors:  Chong Xie; Bogoljub Ciric; Shuo Yu; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2015-12-21       Impact factor: 3.478

10.  IL-12R beta 2 promotes the development of CD4+CD25+ regulatory T cells.

Authors:  Zhao Zhao; Shuo Yu; Denise C Fitzgerald; Mohamed Elbehi; Bogoljub Ciric; A M Rostami; Guang-Xian Zhang
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.